The latest precision medicine news

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Aug 18, 2021GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a...read more

HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.

Deal strengthens HiberCell’s balance sheet, accelerates clinical programs and expands pre-clinical pipeline through the integration of next generation artificial intelligence (AI) and machine learning (ML) strategies...read more

ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics

Nebula Founder and Renowned Harvard Scientist, George Church, Ph.D., to Spearhead ProPhase Labs New Scientific Advisory Board AUGUST 11, 2021 8:30AM EDT GARDEN CITY, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) — ProPhase...read more

Fulgent Genetics Announces Acquisition of CSI Laboratories

August 09, 2021 04:02 PM Eastern Daylight Time TEMPLE CITY, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on...read more

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

Technology Will Enable Continued End-to-End Automated Workflow Development MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or...read more

Pacific Biosciences Signs Definitive Agreement to Acquire Omniome

Tuesday, July 20, 2021 Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing...read more

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

Company is pioneering true “search and replace” gene editing to address the fundamental genetic causes of disease, restore normal gene function, and potentially provide patients with long-lasting cures Company led by...read more

Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos...read more

Pacific Biosciences and RCIGM Announce its First Collaboration for Whole Genome Sequencing Research

June 23, 2021 HiFi Sequencing will be used on a cohort of rare disease cases with the aim to identify numerous variants, both small and structural, that are not readily detectable by short-read sequencing Pacific...read more

10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping

Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping...read more

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

SAN MATEO, Calif., June 3, 2021 /PRNewswire/ — Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg...read more

Genoox accelerates genomic data community platform expansion with $8M round and appointment of new Board Chair

PALO ALTO, Calif., June 1, 2021 /PRNewswire/ — Genoox, the world’s first community-driven genomic data platform, announced today that it has raised $8 million in a round led by...read more

The Much Needed Narrative Behind Recent Female Representation Among Nobel Laureates

Why I, as an undergraduate student studying science, enjoyed this conversation In Illumina’s SPARK 2021 Conference (April 26-27, 2021), Frances Arnold and Jennifer Doudna discuss the joys, challenges, and ethics of gene...read more

ACMG Releases Two Important Secondary Findings Policies: Announces Recommendations for Future SF Reporting and New SF v3.0 List, with Plans to Update SF List Annually

BETHESDA, MD – May 20, 2021 | The American College of Medical Genetics and Genomics (ACMG) has just released an updated policy statement and gene list for the reporting of secondary findings (SF). Together, these two...read more

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

RWE Alliance Launched by Aetion, Flatiron Health, IQVIA, Syapse, and Tempus May 19, 2021 07:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–Five real-world data (RWD) and analytics organizations today...read more

Enlightenbio Releases New Report: Warehousing Clinical & Genomics Biomedical Data – A Needs & Challenges Analysis Report

New, critical, investigative, and qualitative report analyzes the observations and learnings across the complex components of biomedical data warehousing, querying, and collaboration. Palo Alto, CA, May 13...read more

FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable

Data is the blood being pumped through the organism of personalized medicine and will be – as has always been – the key to the identification of novel biomarkers and potential new therapeutics. We have never...read more

EchelonDx And Cradle Genomics Join Forces To Accelerate Development Of Comprehensive Non-Invasive Prenatal Diagnostic Products

Complementary technologies will transform data analysis and reporting capabilities for prenatal diagnostic testing May 3, 2021, 08:00 AM Eastern Daylight Time RENO, Nev. and SAN DIEGO – May 3, 2021 – Echelon...read more

Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition

Apr 29, 2021 SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) announced today that it has filed an action in the General Court of the European Union asking for annulment of the European Commission’s...read more

Geisinger awarded $3.6 million to study genetics of cancer

Apr. 29, 2021 Contract with National Cancer Institute will leverage data from Geisinger’s MyCode Community Health Initiative DANVILLE, Pa. – The National Cancer Institute (NCI), part of the National Institutes of...read more

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth

BOSTON, April 27, 2021—Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the close of the first $15 million of a planned $30 million Series C from a new life sciences investor. This...read more

BC Platforms Partners with TripleBlind to Power Federated Artificial Intelligence (AI) Data Privacy Approaches

Supporting BCP’s contribution to €6.5 million Finnish-led PRIVASA project BC Platforms (BCP), a global leader in healthcare data management, analytics and access, announced a new strategic partnership with US-based...read more

Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions

Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions SAN FRANCISCO, April 8, 2021 /PRNewswire/ — Invitae...read more

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

Acquisition to support the speed, efficiency and flexibility needed for mainstream global adoption of personalized cancer care and monitoring SAN FRANCISCO, April 5, 2021 /PRNewswire/ — Invitae (NYSE: NVTA)...read more

The Medical Research Community Has a Duty to Be Racially And Ethnically Inclusive in Their Study Demographics

I am currently a third year undergraduate student at Emory University studying Biology and Religion while on the pre-med track. I am also presently the Digital Marketing and Communications Intern at enlightenbio due to...read more

Genomenon Completes $5.3M Financing Round

AI-Driven Genomics Company Uses Investment to Fuel Commercial Expansion March 16, 2021 Ann Arbor, MI Genomenon announced that it has completed a $5.3M financing round in the company. The financing will enable the...read more

Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic...read more

IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical Research

Combining IDT’s high-quality NGS products with Swift’s broad portfolio of library preparation and enrichment products will be transformative for enabling scientists to conduct research more efficiently CORALVILLE, Iowa...read more

Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnostics

TOKYO, March 10, 2021 /PRNewswire/ — Konica Minolta Precision Medicine, Inc. (KMPM) announced today a five-year collaboration with Amazon Web Services, Inc. (AWS). As the Preferred Cloud Provider...read more

Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients

Partnership improves access to genetic counseling services when suspected hereditary cancer gene variant is identified through Foundation Medicine’s tumor testing CAMBRIDGE, Mass. & ST. PETERSBURG, Fla...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.